Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
-
$638,000,000
Company Info
- Founders
- Jeff Galvin
- Company Description
- American Gene Technologies International Inc. (AGT) is a private biotechnology company pursuing cures and treatments for infectious diseases, cancers and monogenic disorders. AGT's programs are designed to: Create immunotherapy for HIV disease with gene modified T cells. AGT is pioneering gene therapy solutions to achieve permanent cures for human diseases, including a possible cure for HIV in clinical trials
- Market
- Healthcare & Wellness
- Coinvestors
- 10X Venture Partners,National Institutes of Health,U.S. Department of Health and Human Services,Gaingels,10X Capital,Alumni Ventures Group
Links